Thursday, 15th November Clinical Oncology Society of Australia Annual Scientific Meeting 2018

7:45AM - 8:45AM
Thursday, 15th November
River View Room 5
Sponsored by:

Speaker: Prof Dorothy Keefe and A/Prof Michael Franco
Description: To discuss the latest antiemetic guideline recommendations and treatment options in chemotherapy induced nausea and vomiting (CINV). This will include the use of NK-1 receptor antagonists or “triple therapy” in patients receiving carboplatin or oxaliplatin – containing chemotherapy agents, emerging evidence in dexamethasone-sparing antiemetic regimens, and data on the NEPA combination as well as olanzapine in CINV control and prevention. This session with explore the data to support the use of TARGIN® tablets in the treatment of chronic cancer pain in daily doses up to 160/80 mg, examine the importance of the ongoing assessment of hepatic function and outline how to manage safe opioid rotation from TARGIN® tablets in light of deteriorating liver function. examine the importance of the ongoing assessment of hepatic function and outline how to manage safe opioid rotation from TARGIN® tablets in light of deteriorating liver function. 

9:00AM - 10:30AM
Thursday, 15th November
Meeting Room 3
Chair: David Ransom
10:30AM - 11:15AM
Thursday, 15th November
Pavilion 1 (Exhibition Area)
12:45PM - 1:30PM
Thursday, 15th November
Riverside Theatre
Chair: Phyllis Butow
1:30PM - 1:45PM
Thursday, 15th November
Riverside Theatre